Sign In
Buy AXDX
$0.0340
+0 (+0%)
At Close: Aug 12, 2025
Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper®
09:15am, Monday, 27'th Nov 2023
Working together to bring rapid, automated microbial identification directly from positive blood culture samples TUCSON, Ariz. , Nov. 27, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXD
Accelerate Diagnostics (AXDX) Loses -25.65% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
11:18am, Wednesday, 22'nd Nov 2023
Accelerate Diagnostics (AXDX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earni
Accelerate Diagnostics, Inc. (AXDX) Q3 2023 Earnings Call Transcript
05:37pm, Thursday, 09'th Nov 2023
Accelerate Diagnostics, Inc. (NASDAQ:AXDX ) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Laura Pierson - IR Officer Jack Phillips - President & Chief Executive Off
Accelerate Diagnostics Scheduled Call to Review 2023 Third Quarter Results.
09:30am, Monday, 30'th Oct 2023
TUCSON, Ariz. , Oct. 30, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, November 9, 2023, at 4:30 p.m.
Accelerate Diagnostics (AXDX) Moves 12.7% Higher: Will This Strength Last?
10:32am, Tuesday, 03'rd Oct 2023
Accelerate Diagnostics (AXDX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further streng
Accelerate Diagnostics, Inc. (AXDX) Q2 2023 Earnings Call Transcript
08:12pm, Thursday, 10'th Aug 2023
Accelerate Diagnostics, Inc. (NASDAQ:AXDX ) Q2 2023 Earnings Conference Call August 10, 2023 4:00 PM ET Company Participants Laura Pierson - IR Officer Jack Phillips - CEO, President & Director David
Accelerate Diagnostics (AXDX) Reports Q2 Loss, Misses Revenue Estimates
07:01pm, Thursday, 10'th Aug 2023
Accelerate Diagnostics (AXDX) came out with a quarterly loss of $2.36 per share versus the Zacks Consensus Estimate of a loss of $1.50. This compares to loss of $2.40 per share a year ago.
Is Accelerate Diagnostics (AXDX) Stock Outpacing Its Medical Peers This Year?
11:23am, Thursday, 29'th Jun 2023
Here is how Accelerate Diagnostics (AXDX) and BellRing Brands (BRBR) have performed compared to their sector so far this year.
Is Accelerate Diagnostics (AXDX) Outperforming Other Medical Stocks This Year?
10:53am, Tuesday, 23'rd May 2023
Here is how Accelerate Diagnostics (AXDX) and Cognition Therapeutics, Inc. (CGTX) have performed compared to their sector so far this year.
Accelerate Diagnostics, Inc. (AXDX) Q1 2023 Earnings Call Transcript
10:36pm, Thursday, 11'th May 2023
Accelerate Diagnostics, Inc. (NASDAQ:AXDX ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Laura Pierson - Investor Relations Jack Phillips - President & Chief Executive
Accelerate Diagnostics (AXDX) Reports Q1 Loss, Misses Revenue Estimates
07:02pm, Thursday, 11'th May 2023
Accelerate Diagnostics (AXDX) came out with a quarterly loss of $0.17 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.25 per share a year ago.
Forget Bargain Hunting, Buy 5 Stocks With Rising P/E
08:24am, Tuesday, 18'th Apr 2023
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Disney (DIS), Casey's General Stores (CASY), OpGen (OPGN), Accelerate Diagnostics (AXDX) and Nekt
Accelerate Diagnostics (AXDX) Upgraded to Buy: What Does It Mean for the Stock?
01:41pm, Monday, 03'rd Apr 2023
Accelerate Diagnostics (AXDX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Accelerate Diagnostics, Inc. (AXDX) Q4 2022 Earnings Call Transcript
10:22pm, Wednesday, 29'th Mar 2023
Accelerate Diagnostics, Inc. (NASDAQ:AXDX ) Q4 2022 Earnings Conference Call March 29, 2023 4:30 PM ET Company Participants Laura Pierson - IR Jack Phillips - President and CEO Steve Reichling - outgo
Accelerate Diagnostics (AXDX) Reports Q4 Loss, Misses Revenue Estimates
07:05pm, Wednesday, 29'th Mar 2023
Accelerate Diagnostics (AXDX) delivered earnings and revenue surprises of 12.50% and 0.93%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stoc
